Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patients.

Journal of hepatology - 1 Jun 2013

Martinot-Peignoux Michelle, Carvalho-Filho Roberto, Lapalus Martine, Netto-Cardoso Ana Carolina Ferreira, Lada Olivier, Batrla Richard, Krause Friedemann, Asselah Tarik, Marcellin Patrick

Abstract excerpt

BACKGROUND & AIMS: Little is currently known about the association between serum HBsAg or HBV DNA levels and the severity of liver disease in chronic hepatitis B (CHB) patients. Therefore, we investigated these relationships in a large cohort of unselected, well-characterized, treatment-naïve CHB...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cross-Sectional Studies
Share to Hepatitis B, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B e Antigens

Share to Hepatitis B Surface Antigens

Share to Hepatitis B virus

Share to Liver Cirrhosis

Share to ROC Curve

Share to Severity of Illness Index

Source

Identifiers

PMID: 23369792
DOI: 10.1016/j.jhep.2013.01.028

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23369792-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patients.PMID 23369792Read ↗

Serum Levels of Hepatitis B Surface Antigen Predict Severity of Fibrosis in Patients With E Antigen-Positive Chronic Hepatitis B.Semantic proximity Read ↗

Can quantitative hepatitis B surface antigen levels predict the severity of liver disease in genotype E Patients?Semantic proximity Read ↗

Clinical significance of serum HBsAg levels and association with liver histology in HBeAg positive chronic hepatitis B.Semantic proximity Read ↗

Serum hepatitis B core antibody titer use in screening for significant fibrosis in treatment-naïve patients with chronic hepatitis B.Semantic proximity Read ↗

Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection.Semantic proximity Read ↗

Precore/Core promoter variants to predict significant fibrosis in both HBeAg positive and negative chronic hepatitis B.Semantic proximity Read ↗

High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels.Semantic proximity Read ↗

How Effective Are Serum Scoring Systems in Predicting Liver Fibrosis Caused by Chronic Hepatitis B? Serum Scoring Systems and Liver FibrosisSemantic proximity Read ↗

Significant hepatic histopathology in chronic hepatitis B patients with serum ALT less than twice ULN and high HBV-DNA levels in Indonesia.Semantic proximity Read ↗

Can we use HCC risk scores to individualize surveillance in chronic hepatitis B infection?Semantic proximity Read ↗

The significance of hepatitis B virus (HBV) genotypes for the disease and treatment outcome among patients with chronic hepatitis B in Serbia.Semantic proximity Read ↗

Clinical significance of quantitative e antigen in a cohort of hepatitis B virus-infected children and adults in North America.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.